These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6310456)
21. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122 [TBL] [Abstract][Full Text] [Related]
23. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of chronic agonist administration on mu-opioid receptor- and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons. Van Vliet BJ; Dotman CH; Wardeh G; Mulder AH; Schoffelmeer AN Life Sci; 1992; 51(10):PL89-94. PubMed ID: 1325016 [TBL] [Abstract][Full Text] [Related]
25. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat. Trovero F; Herve D; Desban M; Glowinski J; Tassin JP Neuroscience; 1990; 39(2):313-21. PubMed ID: 1982345 [TBL] [Abstract][Full Text] [Related]
26. In vivo injection of antibodies directed against the cloned mu opioid receptor blocked supraspinal analgesia induced by mu-agonists in mice. Garzón J; Sánchez-Blázquez P Life Sci; 1995; 56(14):PL237-42. PubMed ID: 7475889 [TBL] [Abstract][Full Text] [Related]
27. Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice. Chien CC; Lee YJ; Fan LW; Ho IK; Tien LT Toxicol Lett; 2012 Jul; 212(1):61-5. PubMed ID: 22564758 [TBL] [Abstract][Full Text] [Related]
28. Effects of morphine and naloxone upon the reactions of rats to a heat stressor. Westbrook RF; Greeley JD; Nabke CP; Swinbourne AL; Harvey A Q J Exp Psychol B; 1991 Aug; 43(3):323-46. PubMed ID: 1658853 [TBL] [Abstract][Full Text] [Related]
29. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception. Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046 [TBL] [Abstract][Full Text] [Related]
30. Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion. Bardo MT; Miller JS; Risner ME Pharmacol Biochem Behav; 1984 Oct; 21(4):591-7. PubMed ID: 6095324 [TBL] [Abstract][Full Text] [Related]
31. Morphine suppression of substantia nigra zona reticulata neurons in the rat: implicated role for a novel striatonigral feedback mechanism. Finnerty EP; Chan SH Eur J Pharmacol; 1979 Nov; 59(3-4):307-10. PubMed ID: 527651 [TBL] [Abstract][Full Text] [Related]
32. Modulation of dopamine release in rat striatal slices by delta opiate agonists. Lubetzki C; Chesselet MF; Glowinski J J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911 [TBL] [Abstract][Full Text] [Related]
33. Mu 1 opioid receptor involvement in maternal behavior. Mann PE; Pasternak GW; Bridges RS Physiol Behav; 1990 Jan; 47(1):133-8. PubMed ID: 2158113 [TBL] [Abstract][Full Text] [Related]
34. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Bodnar RJ; Williams CL; Lee SJ; Pasternak GW Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129 [TBL] [Abstract][Full Text] [Related]
35. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540 [TBL] [Abstract][Full Text] [Related]
36. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors. Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Jensen TS; Yaksh TL Brain Res; 1986 May; 372(2):301-12. PubMed ID: 2871901 [TBL] [Abstract][Full Text] [Related]
38. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. Schmauss C; Yaksh TL J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664 [TBL] [Abstract][Full Text] [Related]
39. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873 [TBL] [Abstract][Full Text] [Related]
40. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]